DaVita Management

Management criteria checks 3/4

DaVita's CEO is Javier Rodriguez, appointed in Jun 2019, has a tenure of 5.42 years. total yearly compensation is $6.71M, comprised of 21% salary and 79% bonuses, including company stock and options. directly owns 1.02% of the company’s shares, worth MX$2.64B. The average tenure of the management team and the board of directors is 5.1 years and 4.3 years respectively.

Key information

Javier Rodriguez

Chief executive officer

US$6.7m

Total compensation

CEO salary percentage	21.0%
CEO tenure	5.4yrs
CEO ownership	1.0%
Management average tenure	5.1yrs
Board average tenure	4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Javier Rodriguez's remuneration changed compared to DaVita's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	US$828m
Jun 30 2024	n/a	n/a	US$860m
Mar 31 2024	n/a	n/a	US$816m
Dec 31 2023	US$7m	US$1m	US$692m
Sep 30 2023	n/a	n/a	US$596m
Jun 30 2023	n/a	n/a	US$454m
Mar 31 2023	n/a	n/a	US$500m
Dec 31 2022	US$3m	US$1m	US$547m
Sep 30 2022	n/a	n/a	US$680m
Jun 30 2022	n/a	n/a	US$834m
Mar 31 2022	n/a	n/a	US$903m
Dec 31 2021	US$3m	US$1m	US$978m
Sep 30 2021	n/a	n/a	US$984m
Jun 30 2021	n/a	n/a	US$883m
Mar 31 2021	n/a	n/a	US$791m
Dec 31 2020	US$73m	US$1m	US$783m
Sep 30 2020	n/a	n/a	US$832m
Jun 30 2020	n/a	n/a	US$824m
Mar 31 2020	n/a	n/a	US$816m
Dec 31 2019	US$17m	US$1m	US$705m
Sep 30 2019	n/a	n/a	US$623m
Jun 30 2019	n/a	n/a	US$548m
Mar 31 2019	n/a	n/a	US$551m
Dec 31 2018	US$8m	US$900k	US$616m
Sep 30 2018	n/a	n/a	US$617m
Jun 30 2018	n/a	n/a	US$698m
Mar 31 2018	n/a	n/a	US$652m
Dec 31 2017	US$8m	US$900k	US$909m

Compensation vs Market: Javier's total compensation ($USD6.71M) is about average for companies of similar size in the MX market ($USD5.72M).

Compensation vs Earnings: Javier's compensation has increased by more than 20% in the past year.

CEO

Javier Rodriguez (53 yo)

5.4yrs

Tenure

US$6,712,328

Compensation

Mr. Javier J. Rodriguez serves as an Independent Director at Gilead Sciences, Inc. since June 15, 2020. He has been Chief Executive Officer and Executive Director of DaVita Inc. since June 1, 2019. Mr. Rod...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Javier Rodriguez	CEO & Executive Director	5.4yrs	US$6.71m	1.02% MX$ 2.6b
Joel Ackerman	CFO & Treasurer	7.8yrs	US$6.87m	0.11% MX$ 292.1m
Kathleen Waters	Chief Legal & Public Affairs Officer	8.5yrs	US$5.61m	0.071% MX$ 183.2m
James Hearty	Chief Compliance Officer	6.7yrs	US$2.73m	0.015% MX$ 37.9m
David Maughan	Chief Operating Officer	less than a year	no data	0.0073% MX$ 18.9m
Christopher Berry	Group VP & Chief Accounting Officer	1.3yrs	no data	no data
Madhu Narasimhan	Chief Information Officer	less than a year	no data	no data
Nic Eliason	Group Vice President of Investor Relations	no data	no data	no data
Jessica Hergenreter	Chief People Officer	less than a year	no data	no data
Misha Palecek	Chief Transformation Officer of U.S. Kidney Care Business	no data	no data	no data
Jeffrey Giullian	Chief Medical Officer of Kidney Care	4.8yrs	no data	no data
Partha Das	Chief Medical Officer of DaVita International	6.3yrs	no data	no data

5.1yrs

Average Tenure

55yo

Average Age

Experienced Management: DVA *'s management team is seasoned and experienced (5.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Javier Rodriguez	CEO & Executive Director	5.4yrs	US$6.71m	1.02% MX$ 2.6b
Charles Berg	Director	17.7yrs	US$322.46k	0.032% MX$ 81.9m
Barbara Desoer	Independent Director	9.1yrs	US$384.96k	0.014% MX$ 36.7m
Phyllis Yale	Independent Director	8.3yrs	US$374.96k	0.019% MX$ 49.4m
Wendy Schoppert	Independent Director	1.3yrs	US$106.86k	0.0019% MX$ 4.8m
Pamela Arway	Independent Chair	15.5yrs	US$497.46k	0.030% MX$ 77.3m
Dennis Pullin	Independent Director	less than a year	no data	0.00037% MX$ 954.9k
Adam Schechter	Independent Director	2.2yrs	US$334.96k	0.0040% MX$ 10.5m
Jason Hollar	Independent Director	2.5yrs	US$364.96k	0.0052% MX$ 13.3m
Gregory Moore	Independent Director	3.2yrs	US$355.89k	0.0066% MX$ 17.1m

4.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: DVA *'s board of directors are considered experienced (4.3 years average tenure).

DaVita Management

Management criteria checks 3/4

Key information

Recent management updates

DaVita Appoints Jessica Hergenreter as Chief People Officer

DaVita Announces Executive Appointments, Effective September 15, 2024

High number of new directors

Independent Director recently sold Mex$12m worth of stock

DaVita Appoints Madhu Narasimhan as Chief Information Officer, Effective June 3, 2024

High number of new directors

Recent updates

Third quarter 2024 earnings released: EPS: US$2.56 (vs US$2.70 in 3Q 2023)

DaVita Appoints Jessica Hergenreter as Chief People Officer

DaVita Inc. to Report Q3, 2024 Results on Oct 29, 2024

DaVita Announces Executive Appointments, Effective September 15, 2024

DaVita Inc. to Report Q2, 2024 Results on Aug 06, 2024

High number of new directors

Independent Director recently sold Mex$12m worth of stock

DaVita Appoints Madhu Narasimhan as Chief Information Officer, Effective June 3, 2024

High number of new directors

DaVita Inc., Annual General Meeting, Jun 06, 2024

DaVita Inc. to Report Q1, 2024 Results on May 02, 2024

Davita Announces Dennis Pullin to Its Board of Directors

DaVita Inc. to Report Q4, 2023 Results on Feb 13, 2024

DaVita Inc. to Report Q3, 2023 Results on Nov 07, 2023

DaVita Inc. Announces Management Changes

DaVita Inc. to Report Q2, 2023 Results on Aug 03, 2023

Chief Legal & Public Affairs Officer recently sold Mex$18m worth of stock

First quarter 2023 earnings released: EPS: US$1.28 (vs US$1.68 in 1Q 2022)

DaVita Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently bought Mex$7.0m worth of stock

Third quarter 2022 earnings released: EPS: US$1.16 (vs US$2.48 in 3Q 2021)

DaVita Inc. to Report Q3, 2022 Results on Oct 28, 2022

DaVita Inc. Appoints Adam H. Schechter to Board of Directors

DaVita Inc. to Report Q2, 2022 Results on Aug 01, 2022

Chief Operating Officer of Kidney Care recently bought Mex$31m worth of stock

Independent Director recently sold Mex$4.4m worth of stock

DaVita Inc., Annual General Meeting, Jun 09, 2022

DaVita Inc. to Report Q1, 2022 Results on May 05, 2022

DaVita Inc. Appoints Jason M. Hollar as Independent Director

Independent Director recently sold Mex$1.6m worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

DaVita Inc. (NYSE:DVA) acquired 17 Dialysis Centers in United States.

DaVita Inc. to Report Q4, 2021 Results on Feb 10, 2022

DaVita Inc. (NYSE:DVA) acquired MedSleuth, Inc.

Third quarter 2021 earnings released: EPS US$2.48 (vs US$1.31 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$2.76 (vs US$1.65 in 2Q 2020)

CFO & Treasurer recently sold Mex$99m worth of stock

DaVita Inc. (NYSE:DVA) acquired a Dialysis Center in US.

Davita's China Affiliate to Invest in Hunan Fangsheng Pharma's Unit for 31.7% Stake

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS US$6.54 (vs US$4.61 in FY 2019)

Revenue misses expectations

Kyros Law Files Legal Claims on Behalf of Davita Inc Investors

DaVita Inc. to Report Q4, 2020 Results on Feb 11, 2021

Renalytix AI plc and DaVita Announce Partnership

DaVita Inc. Announces Management Changes, with Effect from December 15, 2020

Chief Operating Officer of Kidney Care recently sold Mex$55m worth of stock

Chief Legal Officer recently sold Mex$21m worth of stock

Market bids up stock over the past week

DaVita Inc. to Report Q3, 2020 Results on Oct 29, 2020

DaVita Inc. Announces the Retirement of Leanne M. Zumwalt, Group Vice President, Government Affairs

Independent Director recently bought Mex$10m worth of stock

An unknown buyer acquired RMS Lifeline, Inc. from DaVita Inc. (NYSE:DVA).

DaVita Inc. to Report Q2, 2020 Results on Jul 30, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age